Effects of Hypoperfusion in Alzheimer's Disease-Reference-Cited by-同舟云学术

Effects of Hypoperfusion in Alzheimer's Disease

Published:2011-10-04 Issue:s3 Volume:26 Page:123-133
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Austin Benjamin P.¹²³,Nair Veena A.³,Meier Timothy B.⁴,Xu Guofan²,Rowley Howard A.³⁵,Carlsson Cynthia M.²⁶⁵,Johnson Sterling C.²⁶⁵,Prabhakaran Vivek³⁴

Affiliation:

1. UW Cardiovascular Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

2. Department of Veterans Affairs (VA) Geriatric Research, Education and Clinical Center (GRECC), Madison, WI, USA

3. Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

4. Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI, USA

5. Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

6. Department of Medicine, Division of Geriatrics and Gerontology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optical coherence tomography angiography of the retina and choroid in systemic diseases;Progress in Retinal and Eye Research;2024-11

2. Recurrent endothelin-1 mediated vascular insult leads to cognitive impairment protected by trophic factor pleiotrophin;Experimental Neurology;2024-11

3. Multi-omic ADNI CSF and plasma data integration identifies distinct metabolic transitions in disease progression in Alzheimer’s Disease;2024-07-24

4. Diastolic dysfunction in Alzheimer’s disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction;Scientific Reports;2024-07-19

5. Effects on cerebral blood flow after single doses of the β₂ agonist, clenbuterol, in healthy volunteers and patients with mild cognitive impairment or Parkinson's disease;British Journal of Clinical Pharmacology;2024-07-02